Pacemaker implantation
DeviceDe novo implantation, device upgrade to dual chamber or device replacement
NCT Number: NCT05165095
The purpose of the clinical investigation is to document the safety and the performances of the remote monitoring functions of the ALIZEA, BOREA and CELEA pacemakers, i.e. the RAAT, the RVAT and the remote alerts.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Universitätsklinikum Krems, Krems, Austria
All patients will be included just after implantation and will then be followed during 48 months after inclusion.
At each on-site or remote follow-up visit (1 to 3 months, 6, 12, 24 and 48 months), performances of the remote monitoring functions and the cardiac pacing system itself will be measured, and safety will be monitored during the whole clinical investigation duration.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
De novo implantation, device upgrade to dual chamber or device replacement
Time frame: 1 to 3 months post-inclusion visit (M1-M3)
Time frame: 1 to 3 months post-inclusion visit (M1-M3)
Time frame: 1 to 3 months post-inclusion visit (M1-M3)
Time frame: 48 months post-inclusion visit (M48)
Time frame: 48 months post-inclusion visit (M48)
Time frame: 48 months post-inclusion visit (M48)
Time frame: 48 months post-inclusion visit (M48)
Time frame: 48 months post-inclusion visit (M48)
Time frame: 48 months post-inclusion visit (M48)
Time frame: 48 months post-inclusion visit (M48)
Contact information is provided by the study sponsor or research team.
MicroPort CRM
Industry
Acronym: CALLIOPE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07809347
Arrhythmias, Cardiac, Atrial Fibrillation
Wroclaw, Lower Silesian Voivodeship, Poland
View Trial DetailsNCT06056817
Arrhythmias, Cardiac, Bradycardia
Minneapolis, Minnesota, United States
View Trial DetailsNCT00271180
Arrhythmia, Arrhythmias, Cardiac
Birmingham, Alabama, United States
View Trial DetailsNCT07118358
AV Block, Arrhythmias, Cardiac
Ypsilanti, Michigan, United States
View Trial Details